Beyond the Favorable-Risk Label: Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia
Bohyun Kim · 2026
Read Beyond the Favorable-Risk Label: Sequential Measurable Residual Disease and KIT Variant Status in Pediatric Core-Binding Factor Acute Myeloid Leukemia by Bohyun Kim (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13662551.txt.
Description
Bohyun Kim warns that a favorable label can hide risky children inside it. His 2026 editorial discusses childhood core-binding factor leukemia, classed as favorable-risk, yet relapsing in a quarter to a third of cases within ten years.
He walks through a Taiwanese study of one hundred twelve children tracked at six points during therapy. Leftover disease measured late in treatment predicted survival, while the same measure early on said nothing for one subtype. Two ways of counting leftovers added to each other, and the worst outlook paired weak clearance with high counts. A common partner mutation raised risk, but deep clearance erased the penalty. Kim's lesson: the fusion gene names the disease, while the response curve writes its future.
Catalog record
| CREATOR | Bohyun Kim |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |